National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup

Clinical trial NCT02192619 · UNKNOWN

Trial details

NCT number: NCT02192619
Sponsor: Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Status: UNKNOWN
Study type: OBSERVATIONAL

Newly-diagnosed APL (de Novo or Therapy-related)Relapsed APL

Start date: 2014-07-01
Primary completion: 2024-12-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.